FDA Inspection 1100101 - Novartis Pharmaceuticals Corporation - August 21, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Novartis Pharmaceuticals Corporation, with an inspection on August 21, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Novartis Pharmaceuticals Corporation
Inspection Date: August 21, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2

Violation Codes4

21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.180(e)(2)21 CFR 211.192

Full citation text and observation details available on the Dashboard.